Stock SOLARA SOLARA ACTIVE PHARMA SCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Solara Active Pharma Sciences Limited

Equities

SOLARA

INE624Z01016

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 09:03:24 2024-04-25 am EDT 		5-day change 1st Jan Change
560.8 INR +1.67% Intraday chart for Solara Active Pharma Sciences Limited +18.36% +55.28%
Apr. 08 Solara Active Pharma Sciences Limited Approves Appointment of Mohan Muthunarayanan as an Executive Director CI
Mar. 26 Solara Active Pharma Gets Board Nod to Sell 100% Stake in SeQuent Penems MT

Business Summary

Solara Active Pharma Sciences Limited is an India-based company offering diversified, commercial active pharmaceutical ingredients (APIs) and contract manufacturing services in over 70 countries. The Company operates through the API segment. Its commercial and research and development products include Albendazole, Aprepitant (Antiemetic), Artesunate, Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Antitubercular), Ethacrynic Acid (Cardiovascular Agent), Hydralazine Hydrochloride (Anti-Hypertensive), Ibuprofen Sodium Dihydrate (Anti-inflammatory), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (OAB Treatment), Pentoxifylline, and others. The Company works with pharmaceutical companies from North America, Europe, and Japan.

Number of employees: 2,361

Sales per Business

INR in Million2022Weight2023Weight Delta
Active Pharma Ingredient
95.2 %
12,074 95.2 % 13,740 95.2 % +13.80%
Other
4.5 %
378 3.0 % 646 4.5 % +71.00%
Services
0.4 %
231 1.8 % 52 0.4 % -77.59%

Sales per region

INR in Million2022Weight2023Weight Delta
Asia Pacific
58.6 %
8,413 66.3 % 8,460 58.6 % +0.57%
Europe
22.9 %
2,191 17.3 % 3,300 22.9 % +50.57%
Rest of the World
6.5 %
918 7.2 % 940 6.5 % +2.34%
North America
5.0 %
339 2.7 % 721 5.0 % +112.60%
Global
4.5 %
378 3.0 % 646 4.5 % +71.00%
South America
2.6 %
444 3.5 % 372 2.6 % -16.30%

Managers

Managers TitleAgeSince
Poorvank Purohit CEO
 Chief Executive Officer - 23-02-02
Sudhir Nambiar CTO
 Chief Tech/Sci/R&D Officer - -
Mohan Muthunarayanan COO
 Chief Operating Officer 52 18-12-31
S. Murali Krishna CMP
 Compliance Officer - 18-04-10
Srinivasan Pagadala HRO
 Human Resources Officer - 23-07-31
Mohan Muthunarayanan
- -
Sundara Moorthy V. PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Arun N. Kumar BRD
 Director/Board Member 63 -
Mohan Muthunarayanan COO
 Chief Operating Officer 52 18-12-31
Ankur Nand Thadani BRD
 Director/Board Member 40 19-05-15
Kartheek Raju BRD
 Director/Board Member - 21-08-03
Kausalya Santhanam BRD
 Director/Board Member 56 18-04-10
Arun Pillai BRD
 Director/Board Member - 21-08-03
Ramakrishnan R. BRD
 Director/Board Member 71 18-04-10
Rajendra Kumar Srivastava BRD
 Director/Board Member 72 Nov. 13
Poorvank Purohit CEO
 Chief Executive Officer - 23-02-02
Rajiv Vijay Nabar BRD
 Director/Board Member 62 Nov. 13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 35,996,267 15,477,770 ( 43.00 %) 0 43.00 %

Shareholders

NameEquities%Valuation
TPG Growth LLC
11.47 %
4,130,321 11.47 % 18 M ₹
Spiracca Ventures LLP
10.44 %
3,758,500 10.44 % 17 M ₹
Pronomz Ventures LLP
6.480 %
2,332,463 6.480 % 10 M ₹
Srjr Enterprise LLP
4.723 %
1,700,100 4.723 % 8 M ₹
Arun Pillai
4.635 %
1,668,463 4.635 % 7 M ₹
Keerthapati Ramaraju Ravishankar
3.682 %
1,325,260 3.682 % 6 M ₹
DEVICAM CAPITAL LLP
2.887 %
1,039,298 2.887 % 5 M ₹
Chayadeep Ventures LLP
2.813 %
1,012,400 2.813 % 5 M ₹
Agnus Capital LLP
2.360 %
849,635 2.360 % 4 M ₹
Think Investments LP
2.241 %
806,838 2.241 % 4 M ₹

Company contact information

Solara Active Pharma Sciences Ltd.

Admin Block 27 Vandaloor kelambakkam Road

600127, Chennai

+91 44 4344 6700

http://www.solara.co.in
address Solara Active Pharma Sciences Limited(SOLARA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Solara Active Pharma Sciences Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
551.6 INR
Average target price
350 INR
Spread / Average Target
-36.55%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SOLARA ACTIVE PHARMA SCIENCES LIMITED Stock Solara Active Pharma Sciences Limited
+55.28% 238M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.09% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.24% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.49% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.28% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.49% 219B
NOVARTIS AG Stock Novartis AG
+6.42% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.94% 196B
PFIZER, INC. Stock Pfizer, Inc.
-8.75% 149B
AMGEN INC. Stock Amgen Inc.
-5.21% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SOLARA Stock
  4. Company Solara Active Pharma Sciences Limited